Upstream Bio, Inc
Price
FilingsNewest: 8-K, Regulation FD disclosureSep 1 →InsidersNo open-market buys. 5 insiders sold $77,193, 0 of 10 sales on a 10b5-1 plan.→HoldersFMR 14.9%Orbimed 10.4%Norges Bank 6.9%→Financing →PeersClosest companies: VRDN, MBX, APGE→
From the filings
Figures
- Revenue
- $3.2Mlast 12 months
- Net income
- −$156.5Mlast 12 months
- Operating cash flow
- −$140.0Mlast 12 months
- Cash and equivalents
- $79.4Mat the last balance sheet
- Shares outstanding
- 54.8M shareson issue